Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.25
+0.07 (0.97%)
At close: Mar 9, 2026, 4:00 PM EDT
7.26
+0.01 (0.14%)
After-hours: Mar 9, 2026, 7:18 PM EDT

Climb Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-59.85-73.9-35.12-45.24-47.48
Upgrade
Depreciation & Amortization
0.1----
Upgrade
Asset Writedown & Restructuring Costs
-51.660.18--
Upgrade
Loss (Gain) From Sale of Investments
-2.27-0.76-2.33-0.180.37
Upgrade
Stock-Based Compensation
8.055.5612.816.993.74
Upgrade
Other Operating Activities
0.220.180.10.8511.47
Upgrade
Change in Accounts Payable
1.56-1.14-0.69-0.650.32
Upgrade
Change in Other Net Operating Assets
-2.172.844.450.86-4.49
Upgrade
Operating Cash Flow
-54.36-15.56-20.6-37.37-36.07
Upgrade
Capital Expenditures
-0.19----
Upgrade
Cash Acquisitions
--4.65---
Upgrade
Investment in Securities
3.02-111.4568.9834.44-114.97
Upgrade
Investing Cash Flow
2.83-121.0968.9834.44-114.97
Upgrade
Issuance of Common Stock
0.07130.980.84-83.29
Upgrade
Other Financing Activities
-0.09-0.25---
Upgrade
Financing Cash Flow
-0.02130.730.84-177.23
Upgrade
Foreign Exchange Rate Adjustments
-0.040.3-0.410.25
Upgrade
Net Cash Flow
-51.54-5.8849.53-3.3426.44
Upgrade
Free Cash Flow
-54.54-15.56-20.6-37.37-36.07
Upgrade
Free Cash Flow Per Share
-0.80-0.32-0.76-1.42-2.94
Upgrade
Levered Free Cash Flow
-33.32-9.543.46-20.51-25.3
Upgrade
Unlevered Free Cash Flow
-33.32-9.543.46-20.51-25.3
Upgrade
Change in Working Capital
-0.61.73.760.21-4.17
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.